Literature DB >> 12650885

A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.

W Antoinette Groenewegen1, Connie R Bezzina, J Peter van Tintelen, Theo M Hoorntje, Marcel M A M Mannens, Arthur A M Wilde, Habo J Jongsma, Martin B Rook.   

Abstract

UNLABELLED: The Long QT3 syndrome is associated with mutations in the cardiac sodium channel gene SCN5A.
OBJECTIVE: The aim of the present study was the identification and functional characterization of a mutation in a family with the long QT3 syndrome.
METHODS: The human cardiac sodium channel gene SCN5A was screened for mutations by single-stranded conformation polymorphism. The functional consequences of mutant sodium channels were characterized after expressing mutant and wild-type cRNAs in Xenopus oocytes by two-electrode voltage clamp measurements.
RESULTS: SCN5A screening revealed an A-->G substitution at codon 1768, close to the C-terminal end of domain IVS6, which changes an isoleucine to a valine. Functional expression of mutant I1768V-channels in Xenopus oocytes showed that the voltage-dependence and slope factors of activation and inactivation were unchanged compared to wild-type channels. No difference in persistent TTX-sensitive current could be detected between wild-type and I1768V channels, a channel feature often increased in LQT3 mutants. However, I1768V mutant channels recovered faster from inactivation (2.4 times) than wild-type channels and displayed less slow inactivation.
CONCLUSIONS: We postulate that severe destabilization of the inactivated state leads to increased arrhythmogenesis and QT prolongation in I1768V mutation carriers in the absence of a persistent inward sodium current.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650885     DOI: 10.1016/s0008-6363(02)00838-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.

Authors:  Hai Huang; Silvia G Priori; Carlo Napolitano; Michael E O'Leary; Mohamed Chahine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

2.  A conserved ring of charge in mammalian Na+ channels: a molecular regulator of the outer pore conformation during slow inactivation.

Authors:  Wei Xiong; Yousaf Z Farukhi; Yanli Tian; Deborah Disilvestre; Ronald A Li; Gordon F Tomaselli
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

3.  Cardiac channelopathy causing sudden death as revealed by molecular autopsy.

Authors:  Silke Kauferstein; Nadine Kiehne; Steve Peigneur; Jan Tytgat; Hansjürgen Bratzke
Journal:  Int J Legal Med       Date:  2012-02-28       Impact factor: 2.686

Review 4.  Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.

Authors:  Weihua Song; Weinian Shou
Journal:  Pediatr Cardiol       Date:  2012-03-30       Impact factor: 1.655

Review 5.  Computational approaches to understand cardiac electrophysiology and arrhythmias.

Authors:  Byron N Roberts; Pei-Chi Yang; Steven B Behrens; Jonathan D Moreno; Colleen E Clancy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

6.  Genetic analysis of Brugada syndrome and congenital long-QT syndrome type 3 in the Chinese.

Authors:  Peng Liang; Wenling Liu; Cuilan Li; Wuhua Tao; Lei Li; Dayi Hu
Journal:  J Cardiovasc Dis Res       Date:  2010-04

7.  The efficacy of Ranolazine on E1784K is altered by temperature and calcium.

Authors:  Mena Abdelsayed; Manpreet Ruprai; Peter C Ruben
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.